Alexandria Real Estate Equities
Alexandria’s 888,000 SQFT Life Sciences Development Continues to Move Forward in Bellevue
Two-tower project at 1445 120th Avenue NE receives environmental approval as part of larger Pine Forest campus transformation The shift from traditional office...
Alexandria Sells 53,000 SQFT Seattle Office Building for $5MM
Life sciences landlord exits historic Sodo property; Puget Properties affiliate steps in as buyer A Seattle office building has been purchased at a...
Bothell’s Biotech Blues: A Life Sciences Hub Under Pressure
A string of facility closures and workforce cuts threatens the Seattle suburb’s ambitions to become a major biotech center The signs of distress...
Alexandria Real Estate Posts Third Consecutive Quarterly Loss as Life Science Sector Challenges Persist
Alexandria Real Estate Equities reported a net loss of $0.64 per share for Q2 2025, marking its third consecutive quarterly loss amid declining...
UW Abandons 345,000 SQFT Anchor Project for Seattle Innovation District at Portage Bay Crossing Amid Financial Pressures
University cites budget constraints and market shifts as $252 million Brightwork building is scrapped The University of Washington has pulled the plug on...
Life Science Reality Check: Alexandria’s Q1 Performance Reflects Industry Challenges Despite Executive Optimism
Alexandria Real Estate Equities (ARE), a pure-play life science REIT, reported its Q1 2025 earnings on April 29th with mixed results that suggest...
Alexandria Real Estate Plans an Accelerated Disposition Strategy for 2025
Alexandria Real Estate Equities, Inc. (NYSE: ARE) is executing an ambitious disposition strategy in 2025 as it faces headwinds in the life science...
Seattle Life Sciences Market Poised for Growth Amidst Rising Investment and Development
Seattle’s life sciences sector continues to expand, driven by strong venture capital investment, strategic acquisitions and steady employment growth, according to a recently...
Seattle’s Life Sciences Market Update: New Leases, VC Funding, and Developments
Seattle’s life sciences sector remains one of the most dynamic components of the city’s economy, even as overall investment levels adjust from the...
Alexandria Real Estate Equities Plans $280MM Addition to South Lake Union Campus in Seattle
By The Registry Staff A major development firm is continuing its significant investment in Seattle’s South Lake Union neighborhood with a new $280...
Gilead Sciences to Close Seattle Office, Lay Off 72 Employees Located at Alexandria’s 199 E. Blaine Property
Gilead Sciences Inc., the global biopharmaceutical company renowned for its HIV treatments, is set to close its Seattle office. As outlined in a...
Alexandria Real Estate Equities Buys 88,500 SQFT Office Building in Seattle for $47.6MM
By Kate Snyder One of Seattle’s South Lake Union properties has traded hands after hitting the market last year. The property, an Amazon-leased...
